Shortage Status

Status

Date Posted

Date Posted (dd-mm-yyyy)

  • METHYLPHENIDATE XR ARX methylphenidate hydrochloride 36 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Jul 2024
  • MAXOR EC TABS omeprazole 20 mg

    Availability: Unavailable Deletion from market: 13 Jan 2025
  • BEVACIPTIN bevacizumab 400 mg/16 mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Apr 2025
  • REPATHA evolocumab (rch) 420 mg/3.5 mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 14 Jul 2024
  • CONDYLINE PAINT podophyllotoxin 5mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Jun 2025
  • APX-AMOXICILLIN/CLAVULANIC ACID 500/125 amoxicillin 500 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Nov 2024
    View Detail
  • RASAGILINE SANDOZ rasagiline (as mesilate) 1 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Jun 2025
  • ATROPINE JUNO atropine sulfate monohydrate 600 microgram/1mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Jul 2024
  • ADALICIP adalimumab 40 mg/0.4 mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Feb 2025
    View Detail
  • ADALICIP adalimumab 40 mg/0.4 mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Jun 2025
    View Detail
  • LIDOCAINE NORIDEM 2% lidocaine (lignocaine) hydrochloride 40 mg/2 mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Oct 2024
  • LIDOCAINE NORIDEM 1% lidocaine (lignocaine) hydrochloride 20 mg/2 mL

    Availability: Unavailable Deletion from market: 14 May 2024